Related Experiment Video
Updated: Jun 19, 2026
Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
Published on: September 25, 2014
COMPARISON OF THE POTENCY OF POLYVALENT ANTIMENINGOCOCCUS SERUM PRODUCED WITH FOUR AND SIX REPRESENTATIVE STRAINS AND
1Division of Laboratories and Research of the New York State Department of Health, Albany.
Abstract:
The potency of a polyvalent antimeningococcus serum, as tested by its agglutination titer, was sacrificed by immunization with a large number of strains of the meningococcus. By immunization with a limited number of representative strains, four or six, carefully selected on account of their antigenic and agglutination properties, the potency was increased three- to tenfold without sacrificing the polyvalency; that is, as tested with at least 70 heterologous strains of the meningococcus. The agglutination titer, unfortunately, is not an entirely satisfactory criterion of therapeutic potency, but it is the only practical method available that determines also the polyvalent action of antimeningococcus serum.
Insights
Selecting a limited number of representative meningococcus strains for immunization significantly boosts polyvalent antimeningococcus serum potency. This approach enhances therapeutic efficacy without compromising broad-spectrum protection against diverse meningococcus strains.
Area of Science:
- Immunology
- Microbiology
- Vaccine Development
Background:
- Polyvalent antimeningococcus serum is crucial for treating Neisseria meningitidis infections.
- Traditional immunization methods using numerous strains can dilute serum potency.
- Assessing serum potency and polyvalency is essential for effective therapeutic use.
Purpose of the Study:
- To investigate methods for enhancing the potency of polyvalent antimeningococcus serum.
- To determine if a reduced, carefully selected set of meningococcus strains can improve serum efficacy.
- To evaluate the impact of strain selection on both serum potency and polyvalency.
Main Methods:
- Immunization of animals with a large number of meningococcus strains versus a limited, representative set.
- Testing serum potency using agglutination titers.
- Evaluating polyvalency by challenging serum against at least 70 heterologous meningococcus strains.
Main Results:
- Immunization with a large number of strains led to reduced serum potency.
- Using four to six carefully selected strains increased serum potency threefold to tenfold.
- This enhanced potency was achieved without sacrificing polyvalency, as confirmed by testing against numerous heterologous strains.
Conclusions:
- Careful selection of immunizing meningococcus strains is critical for developing potent polyvalent antimeningococcus serum.
- Agglutination titer, while imperfect, remains a practical method for assessing serum potency and polyvalency.
- Optimized strain selection offers a viable strategy to improve the therapeutic effectiveness of antimeningococcus therapies.
